A theoretical and spectroscopic study of co-amorphous naproxen and indomethacin

International Journal of Pharmaceutics

Volumn 453, Issue 1, 2013, Pages 80-87

  Löbmann, Korbinian ^a   Laitinen, Riikka ^a   Grohganz, Holger ^b   Strachan, Clare ^a   Rades, Thomas ^a,b   Gordon, Keith C ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Co amorphous; Density functional theory; Infrared spectroscopy; Naproxen indomethacin; Quantum mechanical chemistry

Indexed keywords

CARBOXYLIC ACID; HETERODIMER; HOMODIMER; INDOMETACIN; MONOMER; NAPHTHALENE; NAPROXEN;

ARTICLE; DENSITY FUNCTIONAL THEORY; DRUG CONFORMATION; DRUG STRUCTURE; HYDROGEN BOND; INFRARED SPECTROSCOPY; MECHANICAL TORSION; PRIORITY JOURNAL; QUANTUM MECHANICS;

EID: 84884158112     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2012.05.016     Document Type: Article

References (37)

1. Aaltonen, J., Rades, T., 2009. Towards physico-relevant dissolution testing: the importance of solid-state analysis in dissolution. Dissolution Technol. 16, 47-54.
2. Ali, H.R.H., Edwards, H.G.M., Kendrick, J., Munshi, T., Scowen, I.J., 2007. Vibrational spectroscopic study of budesonide. J. Raman Spectrosc. 38, 903-908.
3. Ali, H.R.H., Edwards, H.G.M., Kendrick, J., Munshi, T., Scowen, I.J., 2010. An experimental and computational study on the epimeric contribution to the infrared spectrum of budesonide. Drug Test. Anal. 2, 447-451.
4. Allesø, M., Chieng, N., Rehder, S., Rantanen, J., Rades, T., Aaltonen, J., 2009. Enhanced dissolution rate and synchronized release of drugs in binary systems through formulation: amorphous naproxen-cimetidine mixtures prepared by mechanical activation. J. Control. Release 136, 45-53.
5. Ayala, A.P., Siesler, H.W., Boese, R., Hoffmann, G.G., Polla, G.I., Vega, D.R., 2006. Solid state characterization of olanzapine polymorphs using vibrational spectroscopy. Int. J. Pharm. 326, 69-79. (Pubitemid 44647742)
6. Bar, I., Bernstein, J., 1985. Conformational polymorphism VI: the crystal and molecular structures of form II, form III, and form V of 4-amino-N-2-pyridinylbenzenesulfonamide (sulfapyridine). J. Pharm. Sci. 74, 255-263. (Pubitemid 15105912)
7. Bernstein, J., Hagler, A.T., 1978. Conformational polymorphism. The influence of crystal structure on molecular conformation. J. Am. Chem. Soc. 100, 673-681.
8. Borba, A., Gómez-Zavaglia, A., Fausto, R., 2009. Molecular structure, infrared spectra, and photochemistry of isoniazid under cryogenic conditions. J Phys. Chem. A 113, 9220-9230.
9. Chesalov, Y.A., Baltakhinov, V.P., Drebushchak, T.N., Boldyreva, E.V., Chukanov, N.V., Drebushchak, V.A., 2008. FT-IR and FT-Raman spectra of five polymorphs of chlorpropamide. Experimental study and ab initio calculations. J. Mol. Struct. 891, 75-86.
10. Chieng, N., Aaltonen, J., Saville, D., Rades, T., 2009. Physical characterization and stability of amorphous indomethacin and ranitidine hydrochloride binary systems prepared by mechanical activation. Eur. J. Pharm. Biopharm. 71, 47-54.
11. Chieng, N., Rades, T., Aaltonen, J., 2011. An overview of recent studies on the analysis of pharmaceutical polymorphs. J. Pharm. Biomed. Anal. 55, 618-644.
12. Frisch, M.J., Trucks, G.W., Schlegel, H.B., Scuseria, G.E., Robb, M.A., Cheeseman, J.R., Scalmani, G., Barone, V., Mennucci, B., Petersson, G.A., Nakatsuji, H., Caricato, M., Li, X., Hratchian, H.P., Izmaylov, A.F., Bloino, J.Z., Zheng, G., Sonnenberg, J.L., Hada, M., Ehara, M., Toyota, K., Fukuda, R., Hasegawa, J., Ishida, M., Nakajima, T., Honda, Y., Kitao, O., Nakai, H., Vreven, T., Montgomery, J.J.A., Peralta, J.E., Ogliaro, F., Bearpark, M., Heyd, J.J., Brothers, E., Kudin, K.N., Staroverov, V.N., Kobayashi, R., Normand, J., Raghavachari, K., Rendell, A., Burant, J.C., Iyengar, S.S., Tomasi, J., Cossi, M., Rega, N., Millam, N.J., Klene, M., Knox, J.E., Cross, J.B., Bakken, V., Adamo, C., Jaramillo, J., Gomperts, R., Stratmann, R.E., Yazyev, O., Austin, A.J., Cammi, R., Pomelli, C., Ochterski, J.W., Martin, R.L., Morokuma, K., Zakrzewski, V.G., Voth, G.A., Salvador, P., Dannenberg, J.J., Dapprich, S., Daniels, A.D., Farkas, Ö., Foresman, J.B., Ortiz, J.V., Cioslowski, J., Fox, D.J., 2009. Gaussian 09, Revision A.1. Gaussian, Inc., Wallingford, CT.
13. Gordon, K.C., McGoverin, C.M., Strachan, C.J., Rades, T., 2007. The use of quantum chemistry in pharmaceutical research as illustrated by case studies of indometacin and carbamazepine. J. Pharm. Pharmacol. 59, 271-277. (Pubitemid 46203065)
14. Hancock, B.C., Zografi, G., 1997. Characteristics and significance of the amorphous state in pharmaceutical systems. J. Pharm. Sci. 86, 1-12.
15. Heinz, A., Gordon, K.C., McGoverin, C.M., Rades, T., Strachan, C.J., 2009a. Understanding the solid-state forms of fenofibrate - a spectroscopic and computational study. Eur. J. Pharm. Biopharm. 71, 100-108.
16. Heinz, A., Strachan, C.J., Gordon, K.C., Rades, T., 2009b. Analysis of solid-state transformations of pharmaceutical compounds using vibrational spectroscopy. J. Pharm. Pharmacol. 61, 971-988.
17. Hu, Y., Erxleben, A., Ryder, A.G., McArdle, P., 2010. Quantitative analysis of sulfathiazole polymorphs in ternary mixtures by attenuated total reflectance infrared, near-infrared and Raman spectroscopy. J. Pharm. Biomed. Anal. 53, 412-420.
18. Iliescu, T., Baia, M., Kiefer, W., 2004. FT-Raman, surface-enhanced Raman spectroscopy and theoretical investigations of diclofenac sodium. Chem. Phys. 298, 167-174.
19. Jubert, A., Legarto, M.L., Massa, N.E., Tévez, L.L., Okulik, N.B., 2006. Vibrational and theoretical studies of non-steroidal anti-inflammatory drugs Ibuprofen [2-(4-isobutylphenyl)propionic acid]; naproxen [6-methoxy-[alpha]-methyl-2-naphthalene acetic acid] and tolmetin acids [1-methyl-5-(4-methylbenzoyl)-1H-pyrrole-2-acetic acid]. J. Mol. Struct. 783, 34-51. (Pubitemid 43183782)
20. Kim, Y., Song, H., 1984. The molecular structure of (+)-6-methoxy- α-methyl-2-naphthaleneacetic acid determined by X-ray method. Arch. Pharmacal Res. 7, 137-139.
21. Kim, Y., Song, H., Park, I., 1987. Refinement of the structure of naproxen, (+)-6-methoxy-α-methyl-2-naphthaleneacetic acid. Arch. Pharmacal Res. 10, 232-238.
22. Kistenmacher, T.J., Marsh, R.E., 1972. Crystal and molecular structure of an antiinflammatory agent, indomethacin, 1-(p-chlorobenzoyl)-5-methoxy-2- methylindole-3-acetic acid. J. Am. Chem. Soc. 94, 1340-1345.
23. Löbmann, K., Laitinen, R., Grohganz, H., Gordon, K.C., Strachan, C., Rades, T., 2011. Coamorphous drug systems: enhanced physical stability and dissolution rate of indomethacin and naproxen. Mol. Pharma. 8, 1919-1928.
24. Löbmann, K., Strachan, C., Grohganz, H., Rades, T., Korhonen, O., Laitinen, R., 2012. Co-amorphous simvastatin and glipizide combinations show improved physical stability without evidence of intermolecular interactions. Eur. J. Pharm. Biopharm. 81 (1), 159-169.
25. Mishra, S., Chaturvedi, D., Tandon, P., Gupta, V.P., Ayala, A.P., Honorato, S.B., Siesler, H.W., 2008. Molecular structure and vibrational spectroscopic investigation of secnidazole using density functional theory. J. Phys. Chem. A 113, 273-281.
26. Müllertz, A., Ogbonna, A., Ren, S., Rades, T., 2010. New perspectives on lipid and surfactant based drug delivery systems for oral delivery of poorly soluble drugs. J. Pharm. Pharmacol. 62, 1622-1636.
27. Nolasco, M.M., Amado, A.M., Ribeiro-Claro, P.J.A., 2006. Computationally-assisted approach to the vibrational spectra of molecular crystals: study of hydrogen-bonding and pseudo-polymorphism. ChemPhysChem 7, 2150-2161.
28. O'Boyle, N.M., Tenderholt, A.L., Langner, K.M., 2008. cclib: a library for package-independent computational chemistry algorithms. J. Comput. Chem. 29, 839-845. (Pubitemid 351364858)
29. Ochterski, J.W., 2000. Thermochemistry in Gaussian. http://www.gaussian. com/g-whitepap/thermo.htm (accessed 25.02.2012).
30. Sagdinc, S., Kandemirli, F., Bayari, S.H., 2007. Ab initio and density functional computations of the vibrational spectrum, molecular geometry and some molecular properties of the antidepressant drug sertraline (Zoloft) hydrochloride. Spectrochim. Acta Part A: Mol. Biomol. Spectrosc. 66, 405-412. (Pubitemid 46027691)
31. Scott, A.P., Radom, L., 1996. Harmonic vibrational frequencies: an evaluation of Hartree-Fock, Møller-Plesset, quadratic configuration interaction, density functional theory, and semiempirical scale factors. J. Phys. Chem. 100, 16502-16513. (Pubitemid 126787989)
32. Srivastava, A., Mishra, S., Tandon, P., Patel, S., Ayala, A.P., Bansal, A.K., Siesler, H.W., 2010. Molecular structure and vibrational spectroscopic analysis of an antiplatelet drug; clopidogrel hydrogen sulphate (form 2) - a combined experimental and quantum chemical approach. J. Mol. Struct. 964, 88-96.
33. Strachan, C.J., Howell, S.L., Rades, T., Gordon, K.C., 2004. A theoretical and spectroscopic study of carbamazepine polymorphs. J. Raman Spectrosc. 35, 401-408.
34. Strachan, C.J., Rades, T., Gordon, K.C., 2007. A theoretical and spectroscopic study of γ-crystalline and amorphous indometacin. J. Pharm. Pharmacol. 59, 261-269. (Pubitemid 46203064)
35. Taylor, L.S., Zografi, G., 1997. Spectroscopic characterization of interactions between pvp and indomethacin in amorphous molecular dispersions. Pharm. Res. 14, 1691-1698. (Pubitemid 28062912)
36. Vueba, M.L., Pina, M.E., Batista de Carvalho, L.A.E., 2008. Conformational stability of ibuprofen: assessed by DFT calculations and optical vibrational spectroscopy. J. Pharm. Sci. 97, 845-859.
37. Vueba, M.L., Pina, M.E., Veiga, F., Sousa, J.J., de Carvalho, L.A.E.B., 2006. Conformational study of ketoprofen by combined DFT calculations and Raman spectroscopy. Int. J. Pharm. 307, 56-65. (Pubitemid 41773252)